Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Stavudine")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 570

  • Page / 23
Export

Selection :

  • and

Benefits in the lipid profile after substitution of abacavir for stavudine: A 48-week prospective studyGARCIA-BENAYAS, Teresa; BLANCO, Francisco; ALCOLEA, Antonio et al.AIDS research and human retroviruses. 2004, Vol 20, Num 12, pp 1289-1292, issn 0889-2229, 4 p.Article

Evaluation of a Systematic Substitution of Zidovudine for Stavudine-Based HAART in a Program Setting in Rural CambodiaISAAKIDIS, Petros; RAGUENAUD, Marie-Eve; PHE, Thong et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 1, pp 48-54, issn 1525-4135, 7 p.Article

Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimensKURITZKES, Daniel R; BASSETT, Roland L; HAZELWOOD, J. Darren et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 1, pp 600-603, issn 1525-4135, 4 p.Article

Real time PCR for rapid determination of susceptibility of adenovirus to antiviral drugsGAINOTTI, Rosana; RICARTE, Carmen; EBEKIAN, Beatriz et al.Journal of virological methods. 2010, Vol 164, Num 1-2, pp 30-34, issn 0166-0934, 5 p.Article

Mitochondrial DNA Subhaplogroups L0a2 and L2a Modify Susceptibility to Peripheral Neuropathy in Malawian Adults on Stavudine Containing Highly Active Antiretroviral TherapyKAMPIRA, Elizabeth; KUMWENDA, Johnstone; VAN OOSTERHOUT, Joep J et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 5, pp 647-652, issn 1525-4135, 6 p.Article

Benefits and risks of stavudine therapy for HIV-associated neurologic complications in UgandaSACKTOR, N; NAKASUJJA, N; SKOLASKY, R. L et al.Neurology. 2009, Vol 72, Num 2, pp 165-170, issn 0028-3878, 6 p.Article

Can We Predict Neuropathy Risk before Stavudine Prescription in a Resource-Limited Setting?AFFANDI, Jacquita S; PRICE, Patricia; IMRAN, Darma et al.AIDS research and human retroviruses. 2008, Vol 24, Num 10, pp 1281-1284, issn 0889-2229, 4 p.Article

Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavirWOOD, Robin; PHANUPHAK, Praphan; GIORDANO, Michael et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 2, pp 684-692, issn 1525-4135, 9 p.Article

Isocratic, simultaneous normal-phase LC separation of four impurities for a stavudine synthesis controlKAZOKA, Helena; MADRE, Marina.Talanta (Oxford). 2005, Vol 67, Num 1, pp 98-102, issn 0039-9140, 5 p.Article

Stavudine Concentrations in Women Receiving Postpartum Antiretroviral Treatment and Their Breastfeeding InfantsFOGEL, Jessica M; TAHA, Taha E; ESHLEMAN, Susan H et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 5, pp 462-465, issn 1525-4135, 4 p.Article

Cost and Cost-Effectiveness of Switching From Stavudine to Tenofovir in First-Line Antiretroviral Regimens in South AfricaROSEN, Sydney; LONG, Lawrence; FOX, Matthew et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 3, pp 334-344, issn 1525-4135, 11 p.Article

Drug-Specific Effect of Nelfinavir and Stavudine on Primary Culture of Human PreadipocytesSAILLAN-BARREAU, Corinne; TABBAKH, Oumaima; CHAVOIN, Jean-Pierre et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 1, pp 20-25, issn 1525-4135, 6 p.Article

Tolérance clinique de la combinaison fixe générique stavudine/lamivudine/névirapine (Triomune®). Étude de 297 cas au Togo = Clinical safety of a generic fixed-dose combination of stavudine/lamivudine/névirapine (Triomune®). Study of 297 cases in TogoMOUHARI-TOURE, A; SAKA, B; KOMBATE, K et al.Bulletin de la Société de pathologie exotique. 2008, Vol 101, Num 5, pp 404-406, issn 0037-9085, 3 p.Article

Severity of the toxicity associated with combinations that include didanosine plus stavudine in HIV-infected experienced patientsHERNDNDEZ, Beatriz; MORENO, Santiago; PEREZ-ELIAS, Maria J et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 5, pp 556-559, issn 1525-4135, 4 p.Article

Lipodystrophy and dyslipidemia among patients taking first-line, world health organization-recommended highly active antiretroviral therapy regimens in western IndiaPUJARI, Sanjay N; DRAVID, Ameet; NAIK, Eknath et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 2, pp 199-202, issn 1525-4135, 4 p.Article

A Longitudinal Study of the Changes in Body Fat and Metabolic Parameters in a South African Population of HIV-Positive Patients Receiving an Antiretroviral Therapeutic Regimen Containing StavudineGEORGE, Jaya A; VENTER, Willem D. F; VAN DEVENTER, Hendrick E et al.AIDS research and human retroviruses. 2009, Vol 25, Num 8, pp 771-781, issn 0889-2229, 11 p.Article

Age and height predict neuropathy risk in patients with HIV prescribed stavudineCHERRY, C. L; AFFANDI, J. S; IMRAN, D et al.Neurology. 2009, Vol 73, Num 4, pp 315-320, issn 0028-3878, 6 p.Article

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive PatientsMALAN, D. R; KRANTZ, Edrich; DAVID, Neal et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 2, pp 161-167, issn 1525-4135, 7 p.Article

Lack of recurrence of hyperlactatemia in HIV-infected patients switched from Stavudine to abacavir or zidovudineLONERGAN, J. Tyler; MCCOMSEY, Grace A; FISHER, Robin L et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 4, pp 935-942, issn 1525-4135, 8 p.Article

Tolerability and Effectiveness of First-Line Regimens Combining Nevirapine and Lamivudine Plus Zidovudine or Stavudine in CameroonLAURENT, Christian; BOURGEOIS, Anke; MPOUDI-NGOLE, Eitel et al.AIDS research and human retroviruses. 2008, Vol 24, Num 3, pp 393-399, issn 0889-2229, 7 p.Article

Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenzBORROTO-ESODA, Katyna; WATERS, Joshua M; BAE, Andrew S et al.AIDS research and human retroviruses. 2007, Vol 23, Num 8, pp 988-995, issn 0889-2229, 8 p.Article

Pyrimidine Nucleoside Depletion Sensitizes to the Mitochondrial Hepatotoxicity of the Reverse Transcriptase Inhibitor StavudineSETZER, Bernhard; LEBRECHT, Dirk; WALKER, Ulrich A et al.The American journal of pathology. 2008, Vol 172, Num 3, pp 681-690, issn 0002-9440, 10 p.Article

Pharmacokinetics of coadministered ritonavir-boosted elvitegravir and zidovudine, didanosine, stavudine, or abacavirRAMANATHAN, Srinivasan; GONG SHEN; HINKLE, John et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 160-166, issn 1525-4135, 7 p.Article

Toxicity and pharmacokinetics of stampidine in mice and ratsUCKUN, Fatih M; CHEN, Chun-Lin; LISOWSKI, Elizabeth et al.Arzneimittel-Forschung. 2003, Vol 53, Num 5, pp 357-367, issn 0004-4172, 11 p.Article

Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against AdenovirusUCKUN, Fatih M; PENDERGRASS, Sharon; QAZI, Sanjive et al.European journal of medicinal chemistry. 2004, Vol 39, Num 3, pp 225-234, issn 0223-5234, 10 p.Article

  • Page / 23